The combination of 1.5-tesla MRI, FDG-PET, and cerebrospinal fluid (CSF) data when added to routine clinical tests significantly increases the ability to predict whether people with mild cognitive impairment will progress to Alzheimer’s disease, according to a study published online December 11 in Radiology.